• 1. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 2. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 3. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 4. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

Chemical Profile of rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid (CAS No. 7375-84-0)

rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 7375-84-0, is a significant compound in the realm of organic chemistry and pharmaceutical research. This molecule, characterized by its cyclopropane ring substituted with a butyl group and a carboxylic acid functional group, has garnered attention due to its unique structural properties and potential applications in synthetic chemistry and drug development.

The stereochemistry of rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid is particularly noteworthy, as the (1R,2R) configuration imparts specific spatial arrangements to the substituents. This chirality can influence the compound's reactivity, solubility, and biological interactions, making it a valuable scaffold for designing chiral drugs and materials. The cyclopropane ring itself is a well-known structural motif in medicinal chemistry, often employed to enhance metabolic stability and binding affinity in drug molecules.

In recent years, rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid has been explored in various research contexts. One particularly intriguing area is its use as an intermediate in the synthesis of more complex molecules. The carboxylic acid moiety allows for further functionalization via esterification, amidation, or other reactions, enabling the creation of a diverse array of derivatives. These derivatives can then be screened for biological activity across different therapeutic targets.

Recent studies have highlighted the potential of cyclopropane-containing compounds in modulating enzyme activity and receptor interactions. For instance, derivatives of rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid have been investigated for their effects on enzymes involved in inflammation and pain signaling. The rigid three-membered ring structure of cyclopropanes often disrupts traditional hydrogen bonding patterns, leading to novel binding modes that can be exploited for therapeutic purposes.

The butyl group attached to the cyclopropane ring in rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid also contributes to its chemical behavior. This alkyl substituent can influence solubility parameters and interact with biological targets in specific ways. Additionally, the presence of both chiral centers (at positions 1 and 2) makes this compound a promising candidate for studying stereoselective processes in organic synthesis.

From a synthetic chemistry perspective, rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid serves as a versatile building block. Its preparation typically involves asymmetric synthesis methods that allow for precise control over stereochemistry. Advances in catalytic asymmetric transformations have made it possible to produce enantiomerically pure forms of this compound with increasing efficiency. Such advancements are crucial for pharmaceutical applications where enantiomeric purity is often required.

The carboxylic acid functionality in rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid also facilitates its incorporation into larger molecular frameworks through condensation reactions with amines or alcohols. This property has been leveraged in the development of novel polymers and materials with tailored properties. For example, polypeptides or polyesters incorporating this motif may exhibit enhanced stability or biodegradability under specific conditions.

In conclusion,rac-(1R,2R)-2-butylcyclopropane-1-carboxylic acid (CAS No. 7375-84-0) represents an intriguing compound with broad applications across organic synthesis and pharmaceutical research. Its unique structural features—comprising a chiral cyclopropane ring substituted with a butyl group and a carboxylic acid—make it a valuable scaffold for developing new drugs and materials. Ongoing research continues to uncover novel synthetic routes and biological functions associated with this molecule, underscoring its importance in modern chemical science.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)